The use of p16Ink4a-high senescent cell reporter mice (p16LUC and p16-CreERT2-tdTomato mice) revealed that p16Ink4a-expressing SnCs progressively increased with age and drove aging and cancer processes in mice (18, 46, 47). Here, CDKN2A is linked to cancer.